The UCSF Rosenman Institute Announces the 2022 Rosenman Innovators

The UCSF Rosenman Institute congratulates the companies selected for the 2022 cohort of the Rosenman Innovators, a select group of emerging medical device and digital health companies commercializing new products and services to improve medicine and benefit patients.

Through the annual Innovators program, Rosenman identifies promising companies, connects them to resources, and integrates them into its network of founders, mentors, investors, and industry leaders. The program is in its seventh year; to date, Rosenman Innovators have raised more than $480 million in capital. The ultimate goal of the program is to assist health technology entrepreneurs in advancing their solutions to market.

?Every year I am amazed at the variety of new technologies and the quality of the companies that apply to the program,? said Christine Winoto, Rosenman?s founder and executive director. ?It is a pleasure to introduce this year?s cohort and welcome them to our community. Millions of patients will benefit from the solutions they are developing. They represent the best of early-stage health tech entrepreneurship.?

Rosenman Innovators selected in previous years include Arterys, the world?s leading vendor-neutral AI platform for medical imaging, which recently received its eighth FDA clearance; Emme, whose smart birth control system was named one of the top 100 innovations of 2021 by TIME magazine; GT Medical Technologies, whose GammaTile? Therapy was FDA-cleared for an expanded indication for patients with newly-diagnosed malignant brain tumors; and Zenflow, which raised $24 million in 2021 to further commercialize its Spring? System to alleviate symptoms of enlarged prostate.

Read Detailed News at: https://rosenmaninstitute.org/2022/06/the-ucsf-rosenman-institute-announces-the-2022-rosenman-innovators/

Company :-UCSF Rosenman Institute

User :- Christine Winoto

Email :-hello@rosenmaninstitute.org

Url :- https://rosenmaninstitute.org/2022/06/the-ucsf-rosenman-institute-announces-the-2022-rosenman-innovators/